Inspiring stories of life-changing care featured during 94.7 WMAS Radiothon for Baystate Children's Hospital
The event, held at the Naismith Memorial Basketball Hall of Fame, will run from 6:00 a.m. to 6:00 p.m. both days. Hosted by the Kellogg Krew, the live broadcast will feature inspiring stories from patients, hospital staff, and community members, highlighting the life-changing care provided by Baystate Children's Hospital.
Spring has sprung at the Smith College Botanic Bulb Show
Attendees of the Radiothon will have the chance to walk the red carpet, take photos, meet the Kellogg Krew, and make donations to support pediatric healthcare services.
The public can contribute in multiple ways:
Visit WMASKids.com
Text WMASKIDS to 51555
Call the Lia Auto Group Phone Bank at 413-794-1111 during the event
Among the many personal journeys shared will be that of Emilia Cecchetelli, the 2025 Children's Miracle Network Ambassador for Baystate Children's Hospital.
Born prematurely at just 26 weeks, Emilia spent 143 days in the Davis Neonatal Intensive Care Unit battling chronic lung disease and craniosynostosis, a condition affecting skull development. Her story is a testament to the dedication of the hospital's medical team and the power of community support.
Eight-year-old Ryan Caney was diagnosed with Guillain-Barré Syndrome. Three years ago, he came down with a cold and began to complain that his feet hurt. Over days, this started to work its way up his body causing him to stop walking. He was diagnosed with Guillain-Barré Syndrome, a rare neurological disorder where your body's immune system mistakenly attacks its nervous system.
Ryan was the 2024 Children's Miracle Network Ambassador for Baystate Children's Hospital and had the chance to go to Disney World, where he was featured during Children's Hospital Week.
Lulu is a 5-year-old girl who underwent surgery for Retropharyngeal abscess and peritonsillar abscess after complaining of neck pain. It's a rare infection that can occur in the neck and throat. After treatment, Lulu has fully recovered and no longer needs extra care.
'Each year, I feel so inspired by the stories we are able to share and the families we are able to meet,' said Chris Kellogg of 94.7 WMAS. 'Baystate Children's Hospital plays such a critical role in our community, and we are happy to support it in any way we can.'
'It really is incredible what our community can accomplish when we come together for an important cause,' said Kathy Tobin, Interim Vice President of Philanthropy at Baystate Health and Executive Director of the Baystate Health Foundation. 'As the only accredited, full-service children's hospital in western Massachusetts, the Radiothon helps provide vital funding for care that spans our region.'
Baystate Children's Hospital is part of the Children's Miracle Network, a nationwide network of 170 hospitals dedicated to improving children's health. All funds raised during the Radiothon stay local, directly benefiting pediatric programs and services at Baystate Children's Hospital.
WWLP-22News, an NBC affiliate, began broadcasting in March 1953 to provide local news, network, syndicated, and local programming to western Massachusetts. Watch the 22News Digital Edition weekdays at 4 p.m. on WWLP.com.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
6 days ago
- San Francisco Chronicle
Nasal spray flu vaccine can now be shipped to your home. Here's how to get it
The first nasal spray flu vaccine, FluMist, can now be shipped to your home. FluMist, made by the drug company AstraZeneca, has been approved in the United States since 2003, but its use was limited to health care settings like hospitals and flu clinics. In 2024, the FDA approved it for at-home administration, making it the first nasal spray vaccine approved for widespread use at home. On Friday, AstraZeneca announced a home delivery service for the product, which infectious disease experts hope will lead to more people getting vaccinated against seasonal influenza. The service is available in 34 states including California, for the upcoming 2025-26 flu season. Prior to the approval for at-home use, FluMust had been given mostly in pediatricians' offices because many children have a fear of needles. As many as 2 in 3 children and 1 in 4 adults have a strong fear of needles, according to CDC estimates. Here's what you need to know about the nasal spray vaccine: It's approved for people aged 2 to 49 Adults can self-administer it; it's given through two sprays, one in each nostril. Children should get it administered by a parent or caregiver. You need a prescription Adults can go to to order the vaccine and will be asked to complete a medical screening questionnaire, AstraZeneca said. A licensed health care provider will review the submission to determine eligibility. Once eligibility is confirmed and insurance is verified, the vaccine will be prescribed and shipped directly to consumers' home on the date they selected. It will come with instructions on how to administer, store and dispose the product. Cost Cost will depend on individuals' insurance, but most insurance plans cover flu vaccines at no cost. There is a $8.99 shipping and processing fee per order. It may not be for everyone Anyone who is wheezing, has asthma, has Guillain-Barre syndrome, has a weakened immune system or has problems with the heart, kidneys or lung should check with their health care provider before getting FluMust, according to AstraZeneca. People who are pregnant or nursing, or who have diabetes, should also check with their doctor first. Children under 5 with a history of wheezing should also check with their doctor. Children and adolescents up to 17 years old who are taking aspirin or medicines containing aspirin should not get FluMust. Side effects The most common side effects are runny or stuffy nose, sore throat and fever over 100 degrees.
Yahoo
07-07-2025
- Yahoo
Regulator warns of small risk of serious condition in people having RSV jab
The medicines regulator has issued a warning to NHS health staff about a small increased risk of a rare condition affecting the nerves in people vaccinated against respiratory syncytial virus (RSV). Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing. It can affect people's senses, movement, breathing and heartbeat – usually starting in the arms and legs before spreading to other areas. The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug alert for the Abrysvo (made by Pfizer) and Arexvy (GSK) vaccines for RSV after they were linked to 21 suspected cases of Guillain-Barre syndrome in adults aged 60 and over. However, the Commission on Human Medicines still advises that 'the benefits of vaccination against RSV outweigh the small risk of developing Guillain-Barre syndrome in older adults'. In its alert, the MHRA said: 'Healthcare professionals should advise all recipients of Abrysvo and Arexvy that they should be alert to signs and symptoms of Guillain-Barre syndrome and, if they occur, to seek immediate medical attention as it requires urgent treatment in hospital.' It warned staff to be alert to the signs and symptoms of the syndrome. It added that there is currently no evidence of an increased risk of Guillain-Barre syndrome in pregnant women following vaccination with Abrysvo, the only RSV vaccine approved for use during pregnancy. The RSV vaccine helps protect against respiratory syncytial virus, which can make older adults and babies seriously ill. RSV can cause bronchiolitis in babies which can cause breathing problems, while it can cause pneumonia in older people, both of which may require hospital stays. The Pfizer RSV vaccine Abrysvo is currently offered on the NHS to adults aged 75 to 79 and to pregnant women. The GSK RSV vaccine Arexvy is not currently available on the NHS but may be available privately in the UK. Symptoms of Guillain-Barre syndrome can include tingling, numbness or pins and needles in feet and hands, muscle weakness and difficulty moving joints. There may also be problems breathing and drooping face muscles or trouble swallowing or speaking. Up to June 2, the MHRA has received 21 Yellow Card reports of suspected Guillain-Barre syndrome in older adults (aged 75-79 where known) following Abrysvo. This is in the context of over 1.9 million doses of Abrysvo administered, it said. Over the same time period, the MHRA has not received any Yellow Card reports of suspected Guillain-Barre syndrome following Arexvy, however there has been very limited use of this vaccine in the UK to date. In the US, one study suggested Abrysvo and Arexvy were associated with nine and seven excess Guillain-Barre syndrome cases per million vaccine doses administered, respectively.
Yahoo
06-06-2025
- Yahoo
$1.2 million raised for kids' health care in Eastern N.C.
GREENVILLE, N.C. (WNCT) — The 40th annual Children's Miracle Network (CMN) Celebration Broadcast raised more than $1.2 million dollars to support pediatric care across eastern North Carolina. According to a press statement, the telethon raised an outstanding $1,278,873 to support pediatric care across eastern North Carolina, bringing the cumulative total raised to $35,680,524. 'This year's Celebration Broadcast was incredibly special, marking 40 years of support for Children's Miracle Network and bringing together those who have made a difference,' said Elise Ironmonger, Director of Programs at the ECU Health Foundation. 'It was amazing to reflect on this journey and connect with our dedicated supporters. We also honored the generous businesses, community groups and individuals whose commitment will continue to save lives and bring hope to the children at Maynard Children's Hospital.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
